BioLife Solutions Inc. (BLFS) is a publicly traded Healthcare sector company. As of September 9, 2026, BLFS trades at $34.94 with a market cap of $1.73B and a P/E ratio of -388.78. BLFS moved -1.27% today. Year to date, BLFS is +44.46%; over the trailing twelve months it is +32.31%. Its 52-week range spans $17.86 to $38.10. Analyst consensus is neutral with an average price target of $31.00. Rallies surfaces BLFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BLFS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BLFS recently traded at $34.94. Market cap is $1.73B. P/E ratio is -388.78. Revenue is $96.21M.
| Metric | Value |
|---|---|
| Price | $34.94 |
| Market Cap | $1.73B |
| P/E Ratio | -388.78 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.10 |
| 52-Week Low | $17.86 |
| Volume | 1.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $96.21M |
| Net Income | $-4.59M |
| Gross Margin | 64.56% |
8 analysts cover BLFS: 0 strong buy, 0 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $31.00.